Abstract
The article has been withdrawn at the request of the authors and editor of the journal “Current Drug Targets”. Bentham Science apologizes to its readers for any inconvenience this may have caused.
The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/journals/current-drug-targets/editorial-policies/
Bentham Science Disclaimer:
It is a condition of publishers that manuscripts submitted to this journal should not be simultaneously submitted or pub-lished elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and while submit- ting the article for publication, the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is trans-ferred to the publishers, if and when the article is accepted for publication.
Current Drug Targets
Title:Withdrawal Notice: Characterization of Glyoxal Modified LDL: Role in the Generation of Circulating Autoantibodies in Type 2 Diabetes Mellitus and Coronary Artery Disease
Volume: 22
Author(s): Md Masum Rizwee, Minhal Abidi, Safia Habib, Abdul Rouf Mir, Asif Ali and Moin Uddin*
Affiliation:
- Department of Biochemistry, Jawaharlal Nehru Medical College, Faculty of Medicine, Aligarh Muslim University, Aligarh, Uttar Pradesh,India
Abstract: The article has been withdrawn at the request of the authors and editor of the journal “Current Drug Targets”. Bentham Science apologizes to its readers for any inconvenience this may have caused.
The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/journals/current-drug-targets/editorial-policies/
Bentham Science Disclaimer:
It is a condition of publishers that manuscripts submitted to this journal should not be simultaneously submitted or pub-lished elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and while submit- ting the article for publication, the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is trans-ferred to the publishers, if and when the article is accepted for publication.
Export Options
About this article
Cite this article as:
Rizwee Masum Md, Abidi Minhal, Habib Safia , Mir Rouf Abdul , Ali Asif and Uddin Moin*, Withdrawal Notice: Characterization of Glyoxal Modified LDL: Role in the Generation of Circulating Autoantibodies in Type 2 Diabetes Mellitus and Coronary Artery Disease, Current Drug Targets 2021; 22 () . https://dx.doi.org/10.2174/1389450122666210114123959
DOI https://dx.doi.org/10.2174/1389450122666210114123959 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
RNA Molecules in the Treatment of Human Diseases
Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response and/or therapy ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Solid Lipid Nanoparticles (SLNs) as a Rising Tool in Drug Delivery Science: One Step Up in Nanotechnology
Current Nanoscience Aza-BODIPY-based Fluorescent and Colorimetric Sensors and Probes
Current Organic Synthesis Molecular Mechanism Behind the Synergistic Activity of Diphenylmethyl Selenocyanate and Cisplatin Against Murine Tumor Model
Anti-Cancer Agents in Medicinal Chemistry Methods to Evaluate the Inhibition of TTR Fibrillogenesis Induced by Small Ligands
Current Medicinal Chemistry Significance of Hepatoprotective Liver Specific Targeted Drug Delivery: A Review on Novel Herbal and Formulation Approaches in the Management of Hepatotoxicity
Current Drug Targets Potential of Selected Indian Herbs for COVID-19
Current Traditional Medicine Some Versatile Medicinal Plants for Healing Wounds: A Review
Current Indian Science Drug Excipients
Current Medicinal Chemistry HPV and Therapeutic Vaccines: Where are We in 2010?
Current Cancer Therapy Reviews Optimization Towards Dose Carving for Head and Neck Treatment Planning
Current Cancer Therapy Reviews Targeting the HIF-1α/Cav-1 Pathway with a Chicory Extract/Daidzein Combination Plays a Potential Role in Retarding Hepatocellular Carcinoma
Current Cancer Drug Targets Sialic Acid and the Central Nervous System: Perspectives on Biological Functions, Detection, Imaging Methods and Manipulation
CNS & Neurological Disorders - Drug Targets Application of MALDI/SELDI Mass Spectrometry to Cancer Biomarker Discovery and Validation
Current Proteomics Concept of Comprehensive Treatment for Osteoarthritis (OA)
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Bowel Damage Assessment in Crohn’s Disease by Magnetic Resonance Imaging
Current Drug Targets Preparation of Knockout Extract for Determination of Really Active Compound Using MAb
Current Drug Discovery Technologies Synthesis, Molecular Docking, and Anticancer Activity of N-Heteroaryl Substituted Flavon Derivatives
Letters in Drug Design & Discovery Neuroinflammation and its Modulation by Flavonoids
Endocrine, Metabolic & Immune Disorders - Drug Targets Decoding Artificial Intelligence in Neuroscience: Applications Beyond Diagnosis
Current Indian Science Xenobiotic Metabolism in Human Skin and 3D Human Skin Reconstructs: A Review
Current Drug Metabolism